{"id":"https://openalex.org/A5092215490","orcid":"https://orcid.org/0009-0008-9263-8197","observed_orcids":["https://orcid.org/0009-0008-9263-8197"],"display_name":"Emily Zyborowicz","raw_author_names":["EMILY ZYBOROWICZ","Emily Zyborowicz","Zyborowicz, Emily"],"full_name":"Zyborowicz, Emily","works_count":19,"cited_by_count":4,"summary_stats":{"2yr_mean_citedness":0.2222222222222222,"h_index":1,"i10_index":0},"ids":{"openalex":"https://openalex.org/A5092215490","orcid":"https://orcid.org/0009-0008-9263-8197","observed_orcids":["https://orcid.org/0009-0008-9263-8197"]},"affiliations":[{"institution":{"id":"https://openalex.org/I5922359","ror":"https://ror.org/05s7dz794","display_name":"International Union Against Tuberculosis and Lung Disease","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210124409","https://openalex.org/I5922359"]},"years":[2025]}],"last_known_institutions":null,"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","count":5,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","count":4,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","count":3,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12918","display_name":"Healthcare Systems and Technology","count":3,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","count":2,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"topic_share":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","value":5.05e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","value":3.32e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12918","display_name":"Healthcare Systems and Technology","value":3.15e-05,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11305","display_name":"Amyloidosis: Diagnosis, Treatment, Outcomes","value":2.38e-05,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","value":1.68e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"x_concepts":[{"id":"71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","score":0.9722331762313843},{"id":"177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","score":0.5074471831321716},{"id":"512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","score":0.48350000381469727},{"id":"126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","score":0.4430930018424988},{"id":"2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","score":0.4262000024318695}],"counts_by_year":[{"year":2023,"works_count":1,"oa_works_count":0,"cited_by_count":0},{"year":2024,"works_count":6,"oa_works_count":3,"cited_by_count":0},{"year":2025,"works_count":4,"oa_works_count":1,"cited_by_count":0},{"year":2026,"works_count":8,"oa_works_count":2,"cited_by_count":4}],"display_name_alternatives":["EMILY ZYBOROWICZ","Emily Zyborowicz","Zyborowicz, Emily"],"block_key":"e zyborowicz","works_api_url":"https://api.openalex.org/works?filter=author.id:A5092215490","awards_count":0,"awards_api_url":"https://api.openalex.org/awards?filter=investigators.author.id:A5092215490","updated_date":"2026-11-11T13:02:13","created_date":"2023-06-21T00:00:00"}